Relapsed Epithelial Ovarian Cancer
1 clinical trials · Condition
◉ Watch Relapsed Epithelial Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer (NCT01940172) | TetraLogic Pharmaceuticals | 2013-11-01 |
Track Relapsed Epithelial Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.